ArticleAmerican journal of translational research2025
Efficacy of integrating surgical interventions with chemoradiotherapy in managing stage IIIC cervical cancer.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis research is principally dedicated to exploring the therapeutic outcomes of integrating surgical intervention with chemoradiotherapy in patients diagnosed with stage IIIC cervical cancer (CC).
methodsA cohort of 141 patients with stage IIIC CC admitted to Chongqing University Three Gorges Hospital were enrolled. Among them, 47 patients underwent radical chemoradiotherapy alone (control group), while 94 patients received surgical intervention in addition to radical chemoradiotherapy (research group). Treatment outcomes were comprehensively evaluated, including short-term therapeutic response, safety profiles, radiotherapy-related complications, long-term treatment efficacy - measured by progression-free survival (PFS) and overall survival (OS) and quality of life (QOL). Univariate and multivariate analyses were performed to identify independent predictors of long-term treatment outcomes.
resultsThe research group exhibited significantly superior short-term efficacy compared to the control group. Additionally, the research group showed a notably lower rate of treatment-associated adverse events, but radiotherapy-induced complications occurred at a similar frequency as in the control group. Long-term outcomes, including PFS, OS, and QOL scores, were also significantly better in the research group. Both univariate and multivariate analyses identified body mass index (BMI) and treatment modality as independent prognostic factors for long-term outcomes in patients with stage IIIC CC.
conclusionsThe integration of surgical intervention with radical chemoradiotherapy yields superior therapeutic outcomes compared to chemoradiotherapy alone in the management of stage IIIC cervical cancer, highlighting its potential as a more effective treatment strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.